Skip to main content
. 2017 Jun 16;113(6):1342–1352. doi: 10.1016/j.bpj.2017.05.032

Figure 6.

Figure 6

Nocodazole selectively decreases CD63 release. (A) Serum-triggered EVs released from HEK293 cells treated with either 12 μM nocodazole or dimethylsulfoxide (DMSO) were harvested by PEG/ConA precipitation and immunoblotted for CD63 and CD9. (B) Quantitation of three independent experiments, with the line indicating the mean. Values show the percent of protein in PEG/ConA EVs from nocodazole treated cells compared to EVs from control untreated cells. The lines indicate mean.